Company / Capital Expenditures
Marker Therapeutics, Inc. Capital Expenditures History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$375.0K
FY2019
5-year range
$0 / $375.0K
FY2018-FY2019
Trend
-
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$374,983 in FY2019.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | - | - |
| FY2019 | $375.0K | - |
| FY2018 | $0 | - |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026